Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2007
11/08/2007US20070259848 N-({[1-(3,4-Dichloro-benzyl)-azetidin-3-ylmethyl]-carbamoyl}-methyl)-2-methoxy-benzamide; inflammatory or allergic condition such as an inflammatory or obstructive airways disease
11/08/2007US20070259049 Process for preparing lansoprazole
11/08/2007US20070258905 Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents
11/08/2007US20070258147 Redox-active structures and devices utilizing the same
11/08/2007DE60021370C5 Piperazinderivate verwendbar als ccr5 antagonisten Piperazine derivatives useful as antagonists ccr5
11/08/2007CA2651072A1 Substituted 2-amino-fused heterocyclic compounds
11/08/2007CA2650914A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
11/08/2007CA2650627A1 Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2649995A1 Amino-ethyl-amino-aryl (aeaa) compounds and their use
11/08/2007CA2649822A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2649650A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2649111A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2648236A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2648124A1 Kinase inhibitors
11/08/2007CA2648019A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2647949A1 P38 inhibitors and methods of use thereof
11/08/2007CA2646624A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2646369A1 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
11/07/2007EP1852432A1 Nitrogenous heterocyclic compound and medicinal use thereof
11/07/2007EP1852431A1 Optically active tetrahydronaphthalene derivative
11/07/2007EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007EP1851219A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase
11/07/2007EP1851212A2 New process for synthesis of proton pump inhibitors
11/07/2007EP1851209A2 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
11/07/2007EP1851204A1 Naphthalene derivatives as modulators of the glucocorticoid receptor
11/07/2007EP1851202A1 Pyridyl acetic acid compounds
11/07/2007EP1851199A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/07/2007EP1850848A1 Tetracyclic sulfonamide compounds and methods of use thereof
11/07/2007EP1773814B1 Substituted oxindol derivatives and medicaments containing the same
11/07/2007EP1613597B1 6-substituted nicotinamide derivatives as opioid receptor antagonists
11/07/2007EP1539712B1 Pyrimidine derivatives and their use as cb2 modulators
11/07/2007EP1400521B1 Piperazine compounds
11/07/2007EP1165523B1 Neurotrophic substituted pyrimidines
11/07/2007CN101068821A Hybrid molecules qa, wherein q is an aminoquinoline and a is an antibiotic or a resistance enzyme inhibitor, their synthesis and their uses as antibacterial agent
11/07/2007CN101068806A (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate
11/07/2007CN101068805A Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
11/07/2007CN101068803A Biaryloxymethylarene carboxylic acid compounds
11/07/2007CN101068794A Quinazolines useful as modulators of ion channels
11/07/2007CN101068788A Quinoline as allosteric enhancers of the gaba-b receptors
11/07/2007CN101068776A Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101068595A Cgrp受体拮抗剂 Cgrp receptor antagonists
11/07/2007CN101068545A Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer disease
11/07/2007CN100347168C Indazolamides with analgesic activity
11/07/2007CN100347167C Process for producing substituted 2-(2-pyridylmethye)sulfinye-1H-benzinmidazoles
11/07/2007CN100347162C N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative
11/07/2007CN100347158C Bicyclic compound
11/07/2007CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
11/07/2007CN100346786C Substituted benzimidazole compounds and their use for the treatment of cancer
11/06/2007US7291738 A (2-methyl-3-pyridinyl)oxy)-3-pyridinyl)urea derivatives for treatment of a disease or disorder of the central nervous system, medical diagnosis
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291729 Reacting 2,3,4-trifluoronitrobenzene with an alkali metal aryloxide, contacting the 3,4-difluoro-2-aryloxynitrobenzene produced with an alkali metal salt of a malonate diester to replace the 4-fluoro group with the malonate; optional further hydrolysis, reduction of the NO2 group, and decarboxylation
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291641 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
11/06/2007US7291640 Substituted triazole derivatives as oxytocin antagonists
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291633 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy
11/06/2007US7291632 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists
11/06/2007US7291631 aminoalkylpyridines, e.g., N-(1H-benzimidazol-2-ylmethyl)-N-(3-methylpyridin-2-ylmethyl)-butane-1,4-diamine; treating HIV infection and inflammatory conditions such as rheumatoid arthritis; elevating progenitor and stem cell counts, as well as white blood cell counts
11/06/2007US7291629 Neurotrophin antagonist compositions
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291619 Melanocortin receptor agonists
11/06/2007US7291618 (3,3-Difluoropyrrolidin-1-yl)-((2S,4S)-4-(4-(pyrimidin-2-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone, usedin treating diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, and the like.
11/06/2007US7291617 Arylamidine derivative or salt thereof
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291611 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain
11/06/2007US7291584 Detergent, cleaning, disinfecting or bleaches; having pyrimidine or triazinebispyrimidine ligands or mixtures of such ligands
11/06/2007CA2263927C Heterocyclic thioesters and ketones
11/01/2007WO2007124337A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124329A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124322A1 Inhibitors of c-fms kinase
11/01/2007WO2007124319A1 Inhibitors of c-fms kinase
11/01/2007WO2007124318A1 Inhibitors of c-fms kinase
11/01/2007WO2007124316A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007WO2007124288A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007WO2007123855A2 Pyrazolines for controlling invertebrate pests
11/01/2007WO2007123516A1 C-fms kinase inhibitors
11/01/2007WO2007123465A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder
11/01/2007WO2007123400A1 Vaccine against nicotine addiction
11/01/2007WO2007122482A1 Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
11/01/2007WO2007122411A1 Diazepan-1-yl-sulfonyl derivatives for the treatment of metabolic syndrome
11/01/2007WO2007122341A2 Specific monocationic monochromophoric hydrazone compounds containing a 2-(benz)imidazolium unit, their synthesis, dyeing compositions comprising them, method of dyeing keratin fibres
11/01/2007WO2007122340A1 Cationic dichromophoric compound containing two units of hydrazone type and comprising a cationic linker arm, dye composition comprising at least one such compound, method for the use thereof and uses
11/01/2007WO2007122274A1 Acetylcholinesterase-inhibiting compounds for treating alzheimer's disease
11/01/2007WO2007122219A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007WO2007122199A1 Synthesis and uses of pyroglutamic acid derivatives
11/01/2007WO2007122173A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007WO2007122103A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007WO2007121687A1 4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament
11/01/2007WO2007121662A1 Diphenyl urea derivatives as kinase inhibitors, compositions and uses thereof
11/01/2007WO2007108936A3 N-substituted-azacyclylamines as histamine-3 antagonists
11/01/2007WO2007106022A3 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof.
11/01/2007WO2007087135A3 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
11/01/2007WO2007079239A3 Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof
11/01/2007WO2007077510A3 Muscarinic receptor antagonists
11/01/2007WO2007072092A3 New phenanthridine derivatives as bradykinin antagonists
11/01/2007WO2007061923A3 Glucokinase activators
11/01/2007WO2006097460A8 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
11/01/2007US20070255061 5-Fluoro-, Chloro-and Cyano-Pyridin-2-Yl-Tetrazoles as Ligands of the Metabotropic Glutamate Receptor-5
11/01/2007US20070255058 Heterocyclic Compounds and Optical Recording Materials
1 ... 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 ... 1080